Rheumatology Archives - Page 5 of 11 - Hospital Healthcare EuropeHospital Healthcare Europe

This website is intended for healthcare professionals only.

Rheumatology

NHS on track to make £300m in savings after arthritis drug deals

NHS on track to make £300m in savings after arthritis drug deals

Adalimumab biosimilar Imraldi launched in European Union

Adalimumab biosimilar Imraldi launched in European Union

Treating giant cell arteritis

JAK inhibitors in the treatment of rheumatoid arthritis

Challenges in the management of psoriatic arthritis

Sobi launches new treatment for patients with rare inflammatory diseases

Sobi launches new treatment for patients with rare inflammatory diseases

Anakinra receives positive opinion from CHMP for the treatment of Still’s disease

Anakinra receives positive opinion from CHMP for the treatment of Still’s disease

Adalimumab biosimilar approved in Europe for the treatment of multiple chronic inflammatory diseases

Adalimumab biosimilar approved in Europe for the treatment of multiple chronic inflammatory diseases

First patient randomised in study evaluating safety and efficacy of anakinra in Still’s disease

First patient randomised in study evaluating safety and efficacy of anakinra in Still’s disease

Efficacy and safety maintained in patients who switched from Humira to biosimilar

Efficacy and safety maintained in patients who switched from Humira to biosimilar

Positive CHMP opinion for adalimumab biosimilar

Positive CHMP opinion for adalimumab biosimilar

Sarilumab approved for the treatment of moderately to severely active rheumatoid arthritis in adults

Sarilumab approved for the treatment of moderately to severely active rheumatoid arthritis in adults